Wedge Capital Management L L P NC Acquires 15,102 Shares of Option Care Health, Inc. $OPCH

Key Points

• Wedge Capital Management increased its stake in Option Care Health by 12.8%, acquiring 15,102 additional shares, bringing its total ownership to approximately 133,389 shares valued at $4.33 million.
• Option Care Health reported second-quarter earnings of $0.41 per share, which exceeded analysts' expectations of $0.40, along with a revenue of $1.42 billion, up 15.4% from the previous year.
• Insider activity included acquisitions by Director Harry M. Jansen Kraemer, Jr., who purchased 36,000 shares at $27.15 each, and Director Norman L. Wright, who bought 3,411 shares at $29.31 each, indicating confidence in the company's future performance.

Wedge Capital Management L L P NC lifted its position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 12.8% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 133,389 shares of the company's stock after purchasing an additional 15,102 shares during the period. Wedge Capital Management L L P NC owned about 0.08% of Option Care Health worth $4,332,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently made changes to their positions in OPCH. Northwestern Mutual Wealth Management Co. boosted its holdings in Option Care Health by 1,492.9% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 892 shares of the company's stock valued at $31,000 after acquiring an additional 836 shares in the last quarter. Brooklyn Investment Group boosted its holdings in Option Care Health by 186.6% in the first quarter. Brooklyn Investment Group now owns 1,198 shares of the company's stock valued at $42,000 after acquiring an additional 780 shares in the last quarter. Public Employees Retirement System of Ohio boosted its holdings in Option Care Health by 21.6% in the fourth quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock valued at $43,000 after acquiring an additional 332 shares in the last quarter. Bessemer Group Inc. boosted its holdings in Option Care Health by 62.3% in the first quarter. Bessemer Group Inc. now owns 1,560 shares of the company's stock valued at $54,000 after acquiring an additional 599 shares in the last quarter. Finally, Wealthquest Corp bought a new stake in Option Care Health in the first quarter valued at $66,000. Institutional investors own 98.05% of the company's stock.

Option Care Health Price Performance

OPCH opened at $28.31 on Monday. Option Care Health, Inc. has a 12-month low of $21.39 and a 12-month high of $35.53. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.81. The business's fifty day simple moving average is $28.83 and its 200-day simple moving average is $31.21. The company has a market capitalization of $4.59 billion, a price-to-earnings ratio of 22.65, a PEG ratio of 1.72 and a beta of 0.83.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its quarterly earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.40 by $0.01. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.The business had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.35 billion. During the same quarter in the prior year, the company earned $0.30 EPS. The business's revenue was up 15.4% compared to the same quarter last year. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. On average, equities research analysts anticipate that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

OPCH has been the subject of several recent research reports. Barrington Research reissued an "outperform" rating and set a $38.00 price objective on shares of Option Care Health in a research report on Thursday, July 10th. JMP Securities raised their price objective on Option Care Health from $36.00 to $38.00 and gave the company a "market outperform" rating in a research report on Thursday, July 31st. Finally, Citigroup reissued an "outperform" rating on shares of Option Care Health in a research report on Thursday, July 31st. Eight research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $35.75.

Insider Activity at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. acquired 36,000 shares of the company's stock in a transaction that occurred on Wednesday, August 20th. The shares were bought at an average price of $27.15 per share, with a total value of $977,400.00. Following the completion of the transaction, the director directly owned 375,390 shares in the company, valued at $10,191,838.50. This trade represents a 10.61% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Norman L. Wright acquired 3,411 shares of the company's stock in a transaction that occurred on Tuesday, September 9th. The shares were bought at an average cost of $29.31 per share, for a total transaction of $99,976.41. Following the transaction, the director owned 15,501 shares of the company's stock, valued at $454,334.31. This represents a 28.21% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have purchased a total of 59,411 shares of company stock valued at $1,627,576 over the last quarter. 0.64% of the stock is owned by corporate insiders.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.